Atlas FDA

iStent inject W Trabecular Micro-Bypass System

FDA premarket approval P170043/S009 · decided 2021-08-31

Approval details

PMA number
P170043
Supplement
S009
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
iStent inject W Trabecular Micro-Bypass System
Generic name
Intraocular pressure lowering implant
Applicant
Glaukos Corporation
Date received
2021-03-25
Decision date
2021-08-31
Days to decision
159 days
Decision code
APPR
Product code
OGO
Advisory committee
Ophthalmic
Expedited review
No
Location
San Clemente, CA
Statement
Approval for an alternate manufacturing process and supplier for the singulator holder assembly.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
iStent infinite Trabecular Micro-Bypass System, Model iS3 (K220032)Glaukos Corporation2022-08-02